World’s First BCI Device Approved for Commercial Use

World’s First BCI Device Approved for Commercial Use

Recently, China granted a landmark brain-computer interface approval for a commercial medical device. This innovative system aims to restore hand-movement ability in paralyzed patients. Specifically, Borui Kang Medical Technology developed the world-first invasive BCI product. Furthermore, the system targets individuals suffering from quadriplegia due to cervical spinal cord injuries. Consequently, this technology provides new hope for those seeking to regain functional independence.

Clinical Impact of Brain-Computer Interface Approval

Moreover, the device uses a minimally invasive extradural implantation method. Electrodes sit directly inside the brain to monitor neural signals. Additionally, the system relies on wireless technology to communicate with an external glove. This glove assists patients in performing grasping tasks. Consequently, clinical data showed significant improvements in hand-grasping ability among trial participants. Therefore, the regulator prioritized this product to enhance patient quality of life.

However, specific eligibility criteria apply to this treatment. Candidates must be between 18 and 60 years old. Furthermore, they must have a stable spinal cord injury diagnosis for at least one year. Patients should also have undergone standard treatments for six months prior. Specifically, they must retain some upper-arm function despite losing hand-grasping skills. Finally, China plans to integrate these products into public use within five years.

Frequently Asked Questions

Q1: What condition does the Borui Kang BCI device treat?

The device treats quadriplegia caused by cervical spinal cord injuries by helping patients regain hand-grasping functionality.

Q2: How does the device work?

Surgeons insert electrodes directly into the brain. These electrodes transmit neural signals wirelessly to a robotic glove that facilitates movement.

Q3: Who is eligible for this BCI treatment?

Adults aged 18 to 60 with a stable spinal cord injury diagnosis of at least one year may qualify for the procedure.

References

1. China approves market launch of brain-computer interface medical device in worldfirst – ETHealthworld
2. Borui Kang Medical Technology: Advancements in Neural Interfacing and Clinical Trials.
3. National Medical Products Administration: Regulatory Roadmap for Neural Technology.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.